Transcriptomic Insights into Polyomavirus Nephropathy in Kidney Transplants: Evaluating the Utility of the Banff Human Organ Transplant Panel

Authors:
  • KHKohta Hatanaka
    Kohta Hatanaka
  • SISari Iwasaki
    Sari Iwasaki
  • STShugo Tanaka
    Shugo Tanaka
  • TTTatsu Tanabe
    Tatsu Tanabe
  • HHHiroshi Harada
    Hiroshi Harada
  • MMMasayoshi Miura
    Masayoshi Miura
  • DNDaigo Nakazawa
    Daigo Nakazawa
  • YIYasushi Ishii
    Yasushi Ishii
  • TYTakako Yamaguchi
    Takako Yamaguchi
  • YKYuko Katayama
    Yuko Katayama
  • SASatoshi Aoyama
    Satoshi Aoyama

Abstract
Background: Polyomavirus nephropathy (PyVN) is a significant complication following kidney transplantation, characterized by tubulointerstitial inflammation that mimics T-cell-mediated rejection (TCMR). The Banff Human Organ Transplant (B-HOT) panel, a transcriptomic analysis tool comprising 770 genes, has been developed to facilitate the diagnosis of allograft rejection. However, its utility in distinguishing PyVN from TCMR remains unclear. Objective: This study aimed to evaluate the biochemical characteristics of PyVN and TCMR using the B-HOT panel, investigate changes after PyVN treatment, and assess the panel’s diagnostic utility. Methods: Formalin-fixed paraffin-embedded tissue samples from 11 PyVN patients were analyzed both at diagnosis and follow-up using the B-HOT panel. Public datasets were compared to identify differentially expressed genes and activated pathways. Prognostic factors were explored based on viral clearance and renal function outcomes. Results: BK VP1 gene expression was significantly elevated in PyVN cases, aiding diagnosis. While tissue homeostasis pathways were upregulated in PyVN compared to TCMR in the original data, no specific pathways were identified in public datasets. Successful viral clearance correlated with enhanced T-cell checkpoint signaling at diagnosis, suggesting its role in immune-mediated viral elimination. Conclusion: The B-HOT panel provides limited utility for diagnosing PyVN beyond viral gene quantification. However, T-cell checkpoint signaling may serve as a prognostic marker for viral clearance and renal function preservation in PyVN cases. Further studies are needed to refine molecular diagnostics for PyVN and improve transplant outcomes.

This publication has 17 references indexed in Scilit: